Medtronic diabetes announces world's first approval for minimed™ 780g system with simplera sync™ disposable, all-in-one sensor

With ce mark approval, the benefits of the minimed™ 780g system are now available with a new sensor that takes less than 10 seconds to insert1 dublin , jan. 8, 2024 /prnewswire/ -- medtronic plc  (nyse:mdt), a global leader in healthcare technology, today announced ce (conformitÉ europÉenne) mark approval for the minimed™ 780g system with simplera sync™, a disposable, all-in-one continuous glucose monitor (cgm) requiring no fingersticks or overtape. simplera sync™ features an improved user experience with a simple, two-step insertion process and is half the size of previous medtronic sensors.
MDT Ratings Summary
MDT Quant Ranking